AMS HP eNews Bulletin 28 April 2016

--

  Australasian Menopause Society  
 
 
Health Professionals eNews28 April 2016
 
  ---  
  Welcome to AMS HP eNews for doctors and other healthcare professionals who have a special interest in women's health. The content covers information and resources relevant to menopause, midlife and the promotion of healthy ageing.

Contents
 
   

20th AMS Congress - Call for Abstracts 

AMS Annual Congress  Fremantle - Western Australia 18-20 November 2016This year our Congress will be at the Esplanade Hotel in Fremantle, right in the heart of the art and cafe culture of the historic port city and close by to beaches, the Swan river and Rottnest Island. 

 

Registrations open 1st June 2016. Until then you can be kept up to date with all the congress information by registering your interest here.

 

AMS invites the submission of papers on original work for consideration for the Congress Program. Authors are invited to submit abstracts for 15 minute oral and/or poster presentations for consideration by the AMS Scientific Program Committee. 

 

Abstracts may be submitted on any topic relevant to the menopause and its treatment. A link to Guidelines in Preparing and formatting your abstract are available from the AMS Website.

 

Abstract submissions close 13 August 2016. 

readmore

 
 

Menopause Essentials Update for Health Professionals:
28 July 2016

Menopause Essentials Update for Health Professionals  28 July 2016 - Hotel Grand Chancellor, Hobart

This workshop is aimed at all GPs, specialists and allied health workers who are seeking a comprehensive update in the field of menopause. Prof Bronwyn Stuckey and Dr Jane Elliot will be presenting and providing case studies on the following topics:

Menopause: What is it? Prof Bronwyn Stuckey

How to manage menopause Dr Jane Elliot

Risks and benefits of HRT Prof Bronwyn Stuckey

Troubleshooting HRT, low libido and testosterone Dr Jane Elliott


Speakers


Professor Bronwyn Stuckey BA MBBS FRACP is President of the Australasian Menopause Society. Bronwyn is an endocrinologist with a clinical and research interest in reproductive endocrinology. She is Consultant Endocrinologist in the Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Nedlands, Western Australia and Clinical Professor in the School of Medicine and Pharmacology, University of Western Australia. She is also the Medical Director of the Keogh Institute for Medical Research which conducts both clinics and research for both men and women. The focus of her research and that of the Institute is on the interface between reproduction and reproductive hormones and metabolism.

 

Dr Jane Elliott, MBBS, is a Past President and a Life Member of the Australasian Menopause Society. Jane is a general practitioner with a longstanding commitment in women’s health especially menopause and midlife women’s health. She is a Clinical Lecturer in the Discipline of Obstetrics and Gynaecology at the University of Adelaide and a member of the Medical and Scientific Committee of Osteoporosis Australia.

 

Venue: Hotel Grand Chancellor, Hobart

 

Registration: $50 for AMS Members, $75 for Non­‐members

 

Registration is now open here...

readmore

 
   

Sorry folks, we were wrong at the time 

Whoever can download from The New England Journal of Medicine and read the paper by Manson and Kunitz entitled 'Menopause management: getting clinical care back on track', or from the relevant commentary in Medscape must do so at their earliest convenience [1,2].

 

As a reminder, the authors were among the WHI study investigators, and Manson was also a Steering Committee member. Needless to detail again the consequences of the misinterpretation of the initial WHI study results, which reduced the use of postmenopausal hormone therapy (HT) by 80% or even more, just because of misunderstanding of its safety profile in recently menopausal women.

 

Many later studies discussed the adverse outcomes of banning HT, mainly related to quality of life issues and bone health. 

readmore

 
   

Compounded Bioidentical Hormones in Endocrinology Practice 

capsulesCustom compounded hormone therapy might seem attractive to your patient but the recent statement from the US Endocrine Society sounds a warning! This scientific statement finds that there is no rationale for prescribing of unregulated, untested, and potentially harmful compounded “bioidentical” hormones.

 

The Australasian Menopause Society (AMS), together with the Endocrine Society of Australia, endorses this new position statement on compounded hormone therapy.

 

The AMS does not support the prescribing of compounded hormones for menopause hormone therapy (MHT).

 

It should be noted that "bioidentical" can equally be applied to many of the TGA approved pharmaceutically produced therapies for use in the menopause.

 

Read abstract of position statement here... 

readmore

 
 

Join AMS for Member's only content

See exclusive commentary on studies such as:  

 

Is there a menopausal medicine?

The driver for this commentary is the recently published Editorial discussing the NICE guidelines on the menopause. Is there a Menopausal medicine? No! There is not! Why? First, because menopause is only the date of the last menstrual period...

 

Early use of postmenopausal hormone therapy may prevent heart disease

 

Findings suggest that after decades of research regarding the effectiveness of MHT on heart disease, timing may be everything...

 

Our Menopause World April 2016

 

See all the news here...
as well as this article:

 

MuslicL, Jokic-Begic N. The experience of perimenopausal distress: examining the role of anxiety and anxiety sensitivity. J Psychosom Obstet Gynaecol 2016;37:26-33

The hormonal changes that occur in perimenopause can result in distress for a significant proportion of women-years before reaching menopause. Previous studies have suggested that various biopsychosocial characteristics and personality traits contribute to more intense reactions to these hormonal changes. In the present study, we examined the contribution of trait anxiety and anxiety sensitivity in predicting the experience of perimenopausal distress in pre- and early perimenopausal women while controlling for some menstrual experiences...  

 

www.menopause.org.au/members/members-update

 

2016 ams congress 1

 
 
  Australasian Menopause Society
PO Box 511, Inverloch VIC 3996
Tel: +61 3 9428 8738
Email: ams@menopause.org.au 
Web: www.menopause.org.au

 
  Join the Australasian Menopause Society  
 
Forward this email to a friend
 
--